One source of relief for moderate to severe acute pain
NUCYNTA, a short‑acting opioid, offers the same active molecule as NUCYNTA ER (tapentadol) extended‑release tablets. NUCYNTA and NUCYNTA ER have different indications. Please see NUCYNTA ER for indications.

POWERFUL
EFFICACY



See phase 3 data demonstrating the strength of NUCYNTA for patients with moderate to severe acute pain.

LEARN MORE

CO‑PAY SAVINGS
AVAILABLE FOR ELIGIBLE PATIENTS



Learn about our co‑pay savings offer for your commercially insured patients.

LEARN MORE